---
layout: post
title: "Government Owned Inventions Available for Licensing or Collaboration: RFXP1 AGONISTS"
date: 2026-02-04 21:49:10 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-16416
original_published: 2025-08-27 00:00:00 +0000
significance: 8.00
---

# Government Owned Inventions Available for Licensing or Collaboration: RFXP1 AGONISTS

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** August 27, 2025 00:00 UTC
**Document Number:** 2025-16416

## Summary

The National Center for Advancing Translational Sciences (NCATS), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is giving notice of the licensing opportunities for the inventions listed below, which are owned by an agency of the U.S. Government, Florida International University (FIU), and University of South Florida (USF). The NCATS has taken the lead in both patenting and licensing via consolidation of rights under an Inter Institutional Agreement (IIA). The inventions are available for licensing and collaboration to achieve expeditious commercialization results of federally funded research and development.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/08/27/2025-16416/government-owned-inventions-available-for-licensing-or-collaboration-rfxp1-agonists)
- API: https://www.federalregister.gov/api/v1/documents/2025-16416

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
